Access Resources
6401 - 6425 of 7540 Results
Title
Year
-
RESTRICTEDTitle: BDNF polymorphism associates with decline in set shifting in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 3Start Page: 1605.e1End Page: 1605.e6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.08.023Citation Count: 35
- Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cells2015RESTRICTEDTitle: Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cellsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 202Issue #:Start Page: 108End Page: 117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2015.02.005Citation Count: 18
-
RESTRICTEDTitle: CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 3Start Page: 271End Page: 276Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.12.027Best OA location URL: https://europepmc.org/articles/pmc4603566?pdf=renderCitation Count: 80
-
RESTRICTEDTitle: Isolation and characterization of antibody fragments selective for toxic oligomeric tauJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 3Start Page: 1342End Page: 1355Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.12.002Best OA location URL: https://europepmc.org/articles/pmc4346425?pdf=renderCitation Count: 24
-
RESTRICTEDTitle: Sarcopenia and impairment in cognitive and physical performanceJournal Name: Clinical Interventions in AgingPublisher: Informa UK LimitedVol:Issue #:Start Page: 663End Page: 663Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/cia.s76275Best OA location URL: https://www.dovepress.com/getfile.php?fileID=24358Citation Count: 86
- Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter2015RESTRICTEDTitle: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence ReporterJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 5Start Page: 1188End Page: 1197Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/cb5010417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927027Citation Count: 50
- Novel Antioxidants Protect Mitochondria from the Effects of Oligomeric Amyloid Beta and Contribute to the Maintenance of Epigenome Function2015RESTRICTEDTitle: Novel Antioxidants Protect Mitochondria from the Effects of Oligomeric Amyloid Beta and Contribute to the Maintenance of Epigenome FunctionJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 6Issue #: 4Start Page: 588End Page: 598Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/cn500323qBest OA location URL: https://europepmc.org/articles/pmc4838453?pdf=renderCitation Count: 10
-
RESTRICTEDTitle: Placebo effect of medication cost in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 84Issue #: 8Start Page: 794End Page: 802Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000001282Best OA location URL: https://europepmc.org/articles/pmc4345649?pdf=renderCitation Count: 110
- Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier Genes2015RESTRICTEDTitle: Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier GenesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2015.00027Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2015.00027/pdfCitation Count: 7
-
RESTRICTEDTitle: Computational analysis of the LRRK2 interactomeJournal Name: PeerJPublisher: PeerJVol: 3Issue #:Start Page: e778End Page: e778Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.7717/peerj.778Best OA location URL: https://doi.org/10.7717/peerj.778Citation Count: 49
-
RESTRICTEDTitle: Can Parkinson’s disease be cured by stimulating neurogenesis?Journal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 125Issue #: 3Start Page: 978End Page: 980Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1172/jci80822Best OA location URL: http://www.jci.org/articles/view/80822/files/pdfCitation Count: 10
-
RESTRICTEDTitle: Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 129Issue #: 4Start Page: 565End Page: 583Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-015-1395-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-015-1395-2.pdfCitation Count: 35
-
RESTRICTEDTitle: Identification of Synaptosomal Proteins Binding to Monomeric and Oligomeric α-SynucleinJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 10Issue #: 2Start Page: e0116473End Page: e0116473Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0116473Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0116473&type=printableCitation Count: 63
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study2015RESTRICTEDTitle: Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 138Issue #: 4Start Page: 963End Page: 973Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awu409Best OA location URL: https://academic.oup.com/brain/article-pdf/138/4/963/13798742/awu409.pdfCitation Count: 138
-
RESTRICTEDTitle: Effect of selective LRRK2 kinase inhibition on nonhuman primate lungJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 273Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aaa3634Citation Count: 292
-
RESTRICTEDTitle: Current Concepts in the Treatment of Multiple System AtrophyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 6End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12145Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12145Citation Count: 24
- Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex2015RESTRICTEDTitle: Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 571End Page: 582Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.09.023Best OA location URL: https://europepmc.org/articles/pmc4315751?pdf=renderCitation Count: 74
-
RESTRICTEDTitle: Chemical methods for the proteome-wide identification of posttranslationally modified proteinsJournal Name: Current Opinion in Chemical BiologyPublisher: Elsevier BVVol: 24Issue #:Start Page: 27End Page: 37Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cbpa.2014.10.020Best OA location URL: https://europepmc.org/articles/pmc4308425?pdf=renderCitation Count: 58
- Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects2015RESTRICTEDTitle: Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction EffectsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 2Start Page: 194End Page: 194Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.2757Best OA location URL: https://europepmc.org/articles/pmc5565160?pdf=renderCitation Count: 120
- Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angle2015RESTRICTEDTitle: Gaucher-related synucleinopathies: The examination of sporadic neurodegeneration from a rare (disease) angleJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 125Issue #:Start Page: 47End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.pneurobio.2014.12.001Best OA location URL: https://doi.org/10.1016/j.pneurobio.2014.12.001Citation Count: 62
- Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits2015RESTRICTEDTitle: Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficitsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 74Issue #:Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.016Best OA location URL: https://europepmc.org/articles/pmc4505366?pdf=renderCitation Count: 117
- Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study2015RESTRICTEDTitle: Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site studyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1097End Page: 1104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.10.029Best OA location URL: https://europepmc.org/articles/pmc4315708?pdf=renderCitation Count: 130
-
RESTRICTEDTitle: Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansionsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1223.e1End Page: 1223.e2Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.08.033Best OA location URL: https://europepmc.org/articles/pmc4315721?pdf=renderCitation Count: 26
-
RESTRICTEDTitle: Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 2Start Page: 106End Page: 110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.033Best OA location URL: https://europepmc.org/articles/pmc4306614?pdf=renderCitation Count: 51
- Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain2015RESTRICTEDTitle: Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrainJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1110End Page: 1120Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.047Best OA location URL: https://europepmc.org/articles/pmc4315740?pdf=renderCitation Count: 20